Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions: a Randomized Controlled Study

NCT06563232 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT06563232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06563232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions: a Randomized Controlled Study
Lead sponsor
Huazhong University of Science and Technology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2024
Completion date
February 1, 2026
Enrollment
656 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal neoplasm, excluding pancreas neoplasm, mediastinal neoplasms, pancreatic neoplasms